Rhode Island Ends Medicaid GLP-1 Weight-Loss Coverage, Cuts Noncitizen Eligibility
Rhode Island Medicaid implemented five changes effective Oct. 1, the start of the federal fiscal year. Under the federal H.R. 1 law, asylees, refugees, parolees, and trafficking victims lose Medicaid eligibility unless they qualify through another status; the state estimates fewer than 3,500 noncitizens will be affected, though green card holders, Compact of Free Association migrants, and lawfully residing children and pregnant/postpartum women retain coverage. Separately, driven by the state budget rather than federal law, Rhode Island Medicaid will stop covering GLP-1 drugs like Wegovy and Zepbound when prescribed for weight loss, while continuing coverage for diabetes indications. The state projects the GLP-1 cut will save $6.3 million in general revenue and $20.3 million in combined state-federal funding; managed care plans were directed to review affected patients' treatment plans before the cutoff. Rhode Island is at least the seventh state in 2026 to drop GLP-1 obesity coverage.
Rhode Island Medicaid managed care plans must immediately transition members off weight-loss GLP-1 prescriptions and verify eligibility status for affected noncitizens to avoid coverage gaps and compliance exposure.
Pharmacy · Managed Care · Finance · CHIP
You might also like